OKYO Pharma
normalized goblet cells reduced inflammatory cells a a | OKYO Pharma
Company
Deck Type
Sector
Industry
Deck date
June 2023
Slide
14 of 25
Related slides by other companies
Bausch+Lomb
Results
May 2023
building a global dynamic dry eye disease platform dry eye total revenue for | Bausch+Lomb
Bausch+Lomb
Results
August 2022
global brand platform total revenue for | Bausch+Lomb
Oculis
Results
August 2023
endothelial cell density in study eyes by visit | Oculis
Other recent decks by OKYO Pharma
See all presentations (2 decks)
Shareholder Engagement
March 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights